Shanghai United Cell Biotechnology Co., Ltd.

Shanghai United Cell Biotechnology Co., Ltd. (hereinafter referred to as “SUCB”) was founded in 1995 by Unilab Inc.. Currently, it is affiliated to Brilliance Group and Hillhouse Capital is the major investor of this company. Located in Jinqiao Biotechnology Industrial Park of Shanghai Pilot Free Trade Zone, SUCB is a high-tech enterprise committed to the R&D, production and marketing & sales of genetically engineered vaccines and therapeutic biological products. In 2022, it was recognized as a “Specialized, special and new enterprise” in Shanghai, with a registered capital of $61.15 million.